AI in life sciences: ten legal considerations for drug discovery
A legal review dated 14 September 2026 lists ten legal considerations and risks of using AI in drug discovery and development.
Who is affected and how
- pharmaceuticals
- The legal risks of AI use should be addressed in internal compliance checks.
Sources
- AI in Life Sciences: Ten Legal Considerations and Risks of AI Use in Drug Discovery and Developmentcrowell & moring llp · Sep 14, 2026
- AI in Life Sciences: 10 Legal Risks in Drug Discovery & Development | Crowell & Moring | Crowell & Moring LLPcrowell.com · Sep 14, 2026
Machine-generated summary based on the titles and excerpts of the source articles. The source article is the authority for the facts. News monitoring, not medical advice: consult a doctor for health decisions.